Nimotuzumab 10ml Injection Biomab EGFR

Description

Preface Biomab EGFR Injection:

Biomab EGFR Injection is a targeted cancer therapy containing Nimotuzumab, a humanized monoclonal antibody used in the treatment of squamous cell carcinoma of the head and neck and other EGFR-expressing cancers, often alongside radiotherapy or chemotherapy.

Biomab EGFR Injection is administered by a doctor or healthcare professional in a hospital or clinical setting through intravenous (IV) infusion. It should not be self-administered. Your doctor will decide the dose, frequency, and duration of treatment based on your type of cancer and how well your body responds to it. This medicine is often given in combination with radiation therapy or chemotherapy as part of your overall treatment plan.

Chills and fever are among the most common effects of this medicine, but Nimotuzumab has been found to be very well tolerated, with severe skin toxicity being rare compared to other EGFR-targeting therapies. Your doctor may monitor your blood pressure and general health during treatment. Inform your doctor immediately if you experience any unusual symptoms during or after the infusion.

Uses Of Biomab EGFR Injection:

• Squamous cell carcinoma of the head and neck
• Glioma (brain tumours)
• Used in combination with radiotherapy/chemotherapy for various EGFR-expressing cancers

Benefits Of Biomab EGFR Injection:

1. Squamous cell carcinoma of the head and neck

This is a type of cancer that develops in the tissues lining the head and neck region. Biomab EGFR Injection works by blocking the epidermal growth factor receptor (EGFR), a protein that drives uncontrolled cell division in these cancers, helping control tumour growth when combined with radiation therapy.

2. Glioma

Glioma is a type of tumour that arises from glial cells in the brain or spinal cord. Biomab EGFR Injection is used, including in pediatric and adult patients, to help control the growth of EGFR-expressing tumour cells as part of a broader treatment approach.

Side effects of Biomab EGFR Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Biomab EGFR:

• Chills
• Fever
• Nausea and vomiting
• Dryness of mouth
• Asthenia (weakness)
• Changes in blood pressure (hypertension/hypotension)
• Flushing

Mechanism Of Action Of Biomab EGFR Injection:

Biomab EGFR Injection contains Nimotuzumab, a humanized monoclonal antibody that binds with high specificity to the extracellular domain of the epidermal growth factor receptor (EGFR), a signalling protein that normally controls cell division. In certain cancers, this receptor is altered, causing uncontrolled cell division. By blocking EGFR and preventing ligand binding and receptor activation, Nimotuzumab helps stop the uncontrolled growth and spread of cancer cells, while its selective binding to cells with moderate-to-high EGFR levels results in a notably low toxicity profile.

Contact Us